CN103610795A - 一种杜仲降压口服制剂的制备方法 - Google Patents
一种杜仲降压口服制剂的制备方法 Download PDFInfo
- Publication number
- CN103610795A CN103610795A CN201310657766.2A CN201310657766A CN103610795A CN 103610795 A CN103610795 A CN 103610795A CN 201310657766 A CN201310657766 A CN 201310657766A CN 103610795 A CN103610795 A CN 103610795A
- Authority
- CN
- China
- Prior art keywords
- fluid extract
- eucommia bark
- oral formulations
- preparation
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title abstract description 26
- 241000208689 Eucommia ulmoides Species 0.000 title abstract 5
- 239000000284 extract Substances 0.000 claims abstract description 65
- 239000012530 fluid Substances 0.000 claims abstract description 61
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 63
- 241000208688 Eucommia Species 0.000 claims description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 30
- 238000009472 formulation Methods 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 241000345998 Calamus manan Species 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 235000012950 rattan cane Nutrition 0.000 claims description 8
- 238000002137 ultrasound extraction Methods 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 238000009495 sugar coating Methods 0.000 claims description 3
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 13
- 239000004615 ingredient Substances 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 11
- 206010020772 Hypertension Diseases 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- ZJSJQWDXAYNLNS-UHFFFAOYSA-N (+) pinoresinol-4,4'-di-O-beta-D-glucopyranoside Natural products COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC4C(C(O)C(O)C(CO)O4)O)=CC=3)CO2)=CC=C1OC1OC(CO)C(O)C(O)C1O ZJSJQWDXAYNLNS-UHFFFAOYSA-N 0.000 description 4
- ZJSJQWDXAYNLNS-FUPWJLLWSA-N (2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group COC1=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)CO2)=CC=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZJSJQWDXAYNLNS-FUPWJLLWSA-N 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- IQSFEAHJUMVILC-UHFFFAOYSA-N Isorhynchophyllic acid Natural products CCC1CN2CCC3(C2CC1C(=COC)C(=O)O)C(=O)Nc4ccccc34 IQSFEAHJUMVILC-UHFFFAOYSA-N 0.000 description 4
- DAXYUDFNWXHGBE-VKCGGMIFSA-N Isorhynchophylline Chemical compound O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-VKCGGMIFSA-N 0.000 description 4
- VCNYNWHVJKWJRQ-UHFFFAOYSA-N Isorhynchophylline Natural products CCC1=CN2CCC3(C2CC1C(=COC)C(=O)OC)C(=O)Nc4ccccc34 VCNYNWHVJKWJRQ-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000003276 anti-hypertensive effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical group O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Abstract
Description
项 目 | 原工艺制剂 | 本发明制剂 |
松脂醇二葡萄糖苷 | 0.31% | 0.38% |
钩藤碱 | 0.0035% | 0.004% |
异钩藤碱 | 0.0021% | 0.0026 |
异迷迭香酸苷 | 0.085% | 0.11% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310657766.2A CN103610795B (zh) | 2013-12-09 | 2013-12-09 | 一种杜仲降压口服制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310657766.2A CN103610795B (zh) | 2013-12-09 | 2013-12-09 | 一种杜仲降压口服制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103610795A true CN103610795A (zh) | 2014-03-05 |
CN103610795B CN103610795B (zh) | 2016-01-06 |
Family
ID=50161528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310657766.2A Active CN103610795B (zh) | 2013-12-09 | 2013-12-09 | 一种杜仲降压口服制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103610795B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105876867A (zh) * | 2016-04-29 | 2016-08-24 | 张家界久瑞生物科技有限公司 | 一种含杜仲提取物的电子烟液及其制备方法 |
CN106421020A (zh) * | 2016-10-10 | 2017-02-22 | 徐凤芹 | 芎栀口服制剂及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137666A (zh) * | 2017-06-08 | 2017-09-08 | 合肥市风达农业有限责任公司 | 一种复方安神降压中药制剂及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255844A (ja) * | 2001-02-20 | 2002-09-11 | Kenzen Kyu | 血圧降下製剤 |
CN1593520A (zh) * | 2004-06-18 | 2005-03-16 | 一笑堂(湖南)制药有限公司 | 复方杜仲胶囊及其制备方法 |
CN1733116A (zh) * | 2005-08-16 | 2006-02-15 | 贵阳德昌祥药业有限公司 | 治疗高血压症的药物制剂及其制备方法 |
CN1833686A (zh) * | 2005-03-15 | 2006-09-20 | 遵义廖元和堂药业有限公司 | 一种纯中药降压药物 |
CN101612188A (zh) * | 2009-07-01 | 2009-12-30 | 贵州百花医药股份有限公司 | 杜仲降压中药缓释制剂的制备方法及产品 |
JP2010248212A (ja) * | 2003-01-31 | 2010-11-04 | Yakult Honsha Co Ltd | グリケーション阻害剤及びその利用 |
CN101946849A (zh) * | 2010-08-31 | 2011-01-19 | 王俊杰 | 降压口香糖及其制备方法 |
-
2013
- 2013-12-09 CN CN201310657766.2A patent/CN103610795B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255844A (ja) * | 2001-02-20 | 2002-09-11 | Kenzen Kyu | 血圧降下製剤 |
JP2010248212A (ja) * | 2003-01-31 | 2010-11-04 | Yakult Honsha Co Ltd | グリケーション阻害剤及びその利用 |
CN1593520A (zh) * | 2004-06-18 | 2005-03-16 | 一笑堂(湖南)制药有限公司 | 复方杜仲胶囊及其制备方法 |
CN1833686A (zh) * | 2005-03-15 | 2006-09-20 | 遵义廖元和堂药业有限公司 | 一种纯中药降压药物 |
CN1733116A (zh) * | 2005-08-16 | 2006-02-15 | 贵阳德昌祥药业有限公司 | 治疗高血压症的药物制剂及其制备方法 |
CN101612188A (zh) * | 2009-07-01 | 2009-12-30 | 贵州百花医药股份有限公司 | 杜仲降压中药缓释制剂的制备方法及产品 |
CN101946849A (zh) * | 2010-08-31 | 2011-01-19 | 王俊杰 | 降压口香糖及其制备方法 |
Non-Patent Citations (3)
Title |
---|
孙世林: "复方杜仲颗粒制备工艺与质量标准研究", 《中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑》, no. 03, 15 September 2004 (2004-09-15) * |
张文康: "《中西医结合医学》", 30 June 2000, article "复方杜仲片", pages: 2115 * |
阳元娥等: "夏枯草总黄酮超声提取工艺", 《食品研究与开发》, vol. 32, no. 4, 30 April 2011 (2011-04-30) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105876867A (zh) * | 2016-04-29 | 2016-08-24 | 张家界久瑞生物科技有限公司 | 一种含杜仲提取物的电子烟液及其制备方法 |
CN106421020A (zh) * | 2016-10-10 | 2017-02-22 | 徐凤芹 | 芎栀口服制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103610795B (zh) | 2016-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN101032593A (zh) | 一种治疗痤疮的中药制剂 | |
CN103610795B (zh) | 一种杜仲降压口服制剂的制备方法 | |
CN102716339A (zh) | 治疗尿毒症的中药组合物、其制备方法及应用 | |
CN102526410B (zh) | 一种治疗功能性便秘的药物组合物 | |
CN103330837B (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
CN101618201A (zh) | 一种治疗外阴粘膜白斑的药物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN103432274B (zh) | 一种治疗偏头痛的药物及其制备方法 | |
CN104352672A (zh) | 一种含龟板的治疗糖尿病的中药组合物 | |
CN104906551A (zh) | 一种抗疲劳中药及食品组合物和制备方法 | |
CN105213905A (zh) | 一种防治绝经后骨质疏松症的中药组合物及其应用 | |
CN104840902A (zh) | 一种治疗卵巢肿瘤的中药制剂 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104189289A (zh) | 一种治疗急性黄疸型肝炎的中药及其制备方法 | |
CN104840864B (zh) | 一种治疗小儿脾虚型腹泻的中药制剂 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN104208510A (zh) | 用于治疗慢性肾炎的药物 | |
CN104826080A (zh) | 一种治疗心绞痛的中药制剂 | |
CN105213975A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN104800646A (zh) | 一种治疗灼口综合症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing eucommia ulmoides step-down oral preparation Effective date of registration: 20160304 Granted publication date: 20160106 Pledgee: Shenzhen HongMian two equity investment partnership (L.P.) Pledgor: BAIHUA MEDICAL GROUP CO.,LTD. Registration number: 2016990000168 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20161208 Granted publication date: 20160106 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170608 Granted publication date: 20160106 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20170608 Granted publication date: 20160106 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20200608 Granted publication date: 20160106 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200608 Granted publication date: 20160106 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230608 Granted publication date: 20160106 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20230608 Granted publication date: 20160106 |